[Skip to Navigation]
[Skip to Navigation Landing]
Perspective
July 2015

Not Breathing Easier With the US FDA’s Ban on Chlorofluorocarbons in Inhalers

Author Affiliations
  • 1Department of Medicine, University of California, San Francisco
JAMA Intern Med. 2015;175(7):1086. doi:10.1001/jamainternmed.2015.1714

I recently experienced firsthand the impact of the US Food and Drug Administration’s (FDA) ban on chlorofluorocarbons as described by Jena et al.1 My daughter was home for vacation from college and needed to fill a prescription for an albuterol inhaler (Ventolin). I went to the pharmacy to pick it up, and when the pharmacist handed me the prescription, he said it would be $59.

×